ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15D14305
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Non Steroidal Anti Inflammatory Drugs Market Research Report 2023
BUY CHAPTERS

Global Non-Steroidal Anti-Inflammatory Drugs Market Research Report 2025

Code: QYRE-Auto-15D14305
Report
May 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Bayer
GSK
Dr. Reddy’s Laboratories Ltd.
Viatris
Teva Pharmaceutical Industries Ltd
Johnson and Johnson Services Inc.
Merck& Co. Inc

Non-Steroidal Anti-Inflammatory Drugs Market Size

The global market for Non-Steroidal Anti-Inflammatory Drugs was valued at US$ 22750 million in the year 2024 and is projected to reach a revised size of US$ 32620 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Non-Steroidal Anti-Inflammatory Drugs Market

Non-Steroidal Anti-Inflammatory Drugs Market

Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs.
The Non-Steroidal Anti-Inflammatory Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Steroidal Anti-Inflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Steroidal Anti-Inflammatory Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non-Steroidal Anti-Inflammatory Drugs Market Report

Report Metric Details
Report Name Non-Steroidal Anti-Inflammatory Drugs Market
Accounted market size in year US$ 22750 million
Forecasted market size in 2031 US$ 32620 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Non-Selective NSAIDs
  • COX-2 Selective NSAIDs
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Steroidal Anti-Inflammatory Drugs Market growing?

Ans: The Non-Steroidal Anti-Inflammatory Drugs Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Non-Steroidal Anti-Inflammatory Drugs Market size in 2031?

Ans: The Non-Steroidal Anti-Inflammatory Drugs Market size in 2031 will be US$ 32620 million.

Who are the main players in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The main players in the Non-Steroidal Anti-Inflammatory Drugs Market are Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc., Merck & Co., Inc.

What are the Application segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Applications covered in the Non-Steroidal Anti-Inflammatory Drugs Market report are Dental Pain, Muscle Aches, Pain caused by Gout, Bursitis, Menstrual Cramps, Fever, Others

What are the Type segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs Market report?

Ans: The Types covered in the Non-Steroidal Anti-Inflammatory Drugs Market report are Non-Selective NSAIDs, COX-2 Selective NSAIDs

Recommended Reports

Pain and Analgesics

Inflammatory Diseases

Chronic Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-Selective NSAIDs
1.2.3 COX-2 Selective NSAIDs
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Dental Pain
1.3.3 Muscle Aches
1.3.4 Pain caused by Gout
1.3.5 Bursitis
1.3.6 Menstrual Cramps
1.3.7 Fever
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Perspective (2020-2031)
2.2 Global Non-Steroidal Anti-Inflammatory Drugs Growth Trends by Region
2.2.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Region (2020-2025)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Region (2026-2031)
2.3 Non-Steroidal Anti-Inflammatory Drugs Market Dynamics
2.3.1 Non-Steroidal Anti-Inflammatory Drugs Industry Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Revenue
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Revenue (2020-2025)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-Steroidal Anti-Inflammatory Drugs Revenue
3.4 Global Non-Steroidal Anti-Inflammatory Drugs Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2024
3.5 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs Head office and Area Served
3.6 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Product and Application
3.7 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Type (2020-2025)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Type (2026-2031)
5 Non-Steroidal Anti-Inflammatory Drugs Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs Historic Market Size by Application (2020-2025)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025)
6.4 North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025)
7.4 Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031)
9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025)
9.4 Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size (2020-2031)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Non-Steroidal Anti-Inflammatory Drugs Introduction
11.2.4 Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 GSK plc
11.3.1 GSK plc Company Details
11.3.2 GSK plc Business Overview
11.3.3 GSK plc Non-Steroidal Anti-Inflammatory Drugs Introduction
11.3.4 GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.3.5 GSK plc Recent Development
11.4 Dr. Reddy’s Laboratories Ltd
11.4.1 Dr. Reddy’s Laboratories Ltd Company Details
11.4.2 Dr. Reddy’s Laboratories Ltd Business Overview
11.4.3 Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Introduction
11.4.4 Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.4.5 Dr. Reddy’s Laboratories Ltd Recent Development
11.5 Viatris Inc
11.5.1 Viatris Inc Company Details
11.5.2 Viatris Inc Business Overview
11.5.3 Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Introduction
11.5.4 Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.5.5 Viatris Inc Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Details
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 Johnson And Johnson Services, Inc.
11.7.1 Johnson And Johnson Services, Inc. Company Details
11.7.2 Johnson And Johnson Services, Inc. Business Overview
11.7.3 Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
11.7.4 Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.7.5 Johnson And Johnson Services, Inc. Recent Development
11.8 Merck & Co., Inc.
11.8.1 Merck & Co., Inc. Company Details
11.8.2 Merck & Co., Inc. Business Overview
11.8.3 Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Introduction
11.8.4 Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
11.8.5 Merck & Co., Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Bayer
GSK
Dr. Reddy’s Laboratories Ltd.
Viatris
Teva Pharmaceutical Industries Ltd
Johnson and Johnson Services Inc.
Merck& Co. Inc
List of Tables
 Table 1. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Non-Selective NSAIDs
 Table 3. Key Players of COX-2 Selective NSAIDs
 Table 4. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2020-2025)
 Table 8. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2026-2031)
 Table 10. Non-Steroidal Anti-Inflammatory Drugs Market Trends
 Table 11. Non-Steroidal Anti-Inflammatory Drugs Market Drivers
 Table 12. Non-Steroidal Anti-Inflammatory Drugs Market Challenges
 Table 13. Non-Steroidal Anti-Inflammatory Drugs Market Restraints
 Table 14. Global Non-Steroidal Anti-Inflammatory Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Players (2020-2025)
 Table 16. Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2024)
 Table 17. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Product and Application
 Table 21. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global Non-Steroidal Anti-Inflammatory Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Inc. Company Details
 Table 47. Pfizer Inc. Business Overview
 Table 48. Pfizer Inc. Non-Steroidal Anti-Inflammatory Drugs Product
 Table 49. Pfizer Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Inc. Recent Development
 Table 51. Bayer AG Company Details
 Table 52. Bayer AG Business Overview
 Table 53. Bayer AG Non-Steroidal Anti-Inflammatory Drugs Product
 Table 54. Bayer AG Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 55. Bayer AG Recent Development
 Table 56. GSK plc Company Details
 Table 57. GSK plc Business Overview
 Table 58. GSK plc Non-Steroidal Anti-Inflammatory Drugs Product
 Table 59. GSK plc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 60. GSK plc Recent Development
 Table 61. Dr. Reddy’s Laboratories Ltd Company Details
 Table 62. Dr. Reddy’s Laboratories Ltd Business Overview
 Table 63. Dr. Reddy’s Laboratories Ltd Non-Steroidal Anti-Inflammatory Drugs Product
 Table 64. Dr. Reddy’s Laboratories Ltd Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 65. Dr. Reddy’s Laboratories Ltd Recent Development
 Table 66. Viatris Inc Company Details
 Table 67. Viatris Inc Business Overview
 Table 68. Viatris Inc Non-Steroidal Anti-Inflammatory Drugs Product
 Table 69. Viatris Inc Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 70. Viatris Inc Recent Development
 Table 71. Teva Pharmaceutical Industries Ltd. Company Details
 Table 72. Teva Pharmaceutical Industries Ltd. Business Overview
 Table 73. Teva Pharmaceutical Industries Ltd. Non-Steroidal Anti-Inflammatory Drugs Product
 Table 74. Teva Pharmaceutical Industries Ltd. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 75. Teva Pharmaceutical Industries Ltd. Recent Development
 Table 76. Johnson And Johnson Services, Inc. Company Details
 Table 77. Johnson And Johnson Services, Inc. Business Overview
 Table 78. Johnson And Johnson Services, Inc. Non-Steroidal Anti-Inflammatory Drugs Product
 Table 79. Johnson And Johnson Services, Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 80. Johnson And Johnson Services, Inc. Recent Development
 Table 81. Merck & Co., Inc. Company Details
 Table 82. Merck & Co., Inc. Business Overview
 Table 83. Merck & Co., Inc. Non-Steroidal Anti-Inflammatory Drugs Product
 Table 84. Merck & Co., Inc. Revenue in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025) & (US$ Million)
 Table 85. Merck & Co., Inc. Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Non-Steroidal Anti-Inflammatory Drugs Picture
 Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Non-Selective NSAIDs Features
 Figure 5. COX-2 Selective NSAIDs Features
 Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Dental Pain Case Studies
 Figure 9. Muscle Aches Case Studies
 Figure 10. Pain caused by Gout Case Studies
 Figure 11. Bursitis Case Studies
 Figure 12. Menstrual Cramps Case Studies
 Figure 13. Fever Case Studies
 Figure 14. Others Case Studies
 Figure 15. Non-Steroidal Anti-Inflammatory Drugs Report Years Considered
 Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Region: 2024 VS 2031
 Figure 19. Global Non-Steroidal Anti-Inflammatory Drugs Market Share by Players in 2024
 Figure 20. Global Top Non-Steroidal Anti-Inflammatory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs Revenue in 2024
 Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2020-2031)
 Figure 24. United States Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2020-2031)
 Figure 28. Germany Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs Market Share by Region (2020-2031)
 Figure 36. China Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2020-2031)
 Figure 44. Mexico Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs Market Share by Country (2020-2031)
 Figure 48. Turkey Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Non-Steroidal Anti-Inflammatory Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Pfizer Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 52. Bayer AG Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 53. GSK plc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 54. Dr. Reddy’s Laboratories Ltd Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 55. Viatris Inc Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 56. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 57. Johnson And Johnson Services, Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 58. Merck & Co., Inc. Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Topical Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Non steroidal Anti inflammatory Drugs NSAID Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet NSAIDs Market Research Report 2025
Global Cyclooxygenase 2 Inhibitor Market Research Report 2024
Global Pets NSAIDs Market Research Report 2025
Global Dermatological Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Global Loxoprofen Market Research Report 2024
Global Indometacin Indomethacin Market Research Report 2024
Global Cyclooxygenase 2 Inhibitor COVID 19 Market Research Report 2024
Global Anti inflammatory Drugs for Dental Market Research Report 2024
Global Non Steroidal Anti Inflammatory API Market Research Report 2025
Analgesic and Anti inflammatory API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tenoxicam Market Research Report 2024
Global Indomethacin Tablets Market Research Report 2024
Global Celecoxib Market Insights Forecast to 2030
Global Indoprofen Market Research Report 2024
Global Antiinflammatory Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions